Aspen Neuroscience

Series-B+
aspenneuroscience.com Biotech & Healthcare La Jolla, United States Founded 2018 101-250
Total Funding $339M
Latest Round $115M Series-B+
Last Announced Nov 20, 2025
Investors 21 Backers
Decision Makers 6 Verified

About Aspen Neuroscience

Aspen Neuroscience develops and delivers autologous cell replacement therapies for patients with high unmet medical need, beginning with Parkinson’s disease. It uses a person’s own cells to help restore function. Aspen Neuroscience aims to make personalized cell therapy commercially viable at scale.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters La Jolla, United States
Year Founded 2018
Team Size 101-250
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website aspenneuroscience.com
Domain Registered Date Oct 3, 2018

Social & Network Presence

X / Twitter Profile @AspenNeuro (376 followers) Created on Jul 2019
LinkedIn Corporate Not linked

Company Milestones & Timeline

7 Events
  1. Capital Raise

    Raised $115,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $147,500,000 · Series-B+

  3. Capital Raise

    Raised $70,000,000 · Series-A

  4. Capital Raise

    Raised $6,500,000 · Seed

  5. Milestone

    X account created (@AspenNeuro)

    376 followers

  6. Milestone

    Website domain registered

    aspenneuroscience.com

  7. Milestone

    Company founded

    La Jolla, United States

Investors & Backers

21
Alexandria Venture Investments
ARCH Venture Partners
Axon Ventures
Balyasny Asset Management
Cormorant Asset Management
Domain Associates
Frazier Healthcare Partners
Frazier Life Sciences
GV
Kite Pharma
Lifeforce Capital
LYFE Capital
Medical Excellence Capital
Mirae Asset Capital
Newton Investment Management
NS Investment
OrbiMed
Prebys Ventures
Revelation Partners
S32
Sam Altman

Funding History

4 Rounds
Series-B+ · Nov 20, 2025
Series-B+ · May 18, 2022
$147,500,000 Source
Series-A · Apr 1, 2020
$70,000,000 Source
Seed · Dec 12, 2019
$6,500,000 Source

Founders & Leadership

8

Ana Sousa

Chief Regulatory Officer

Work email & phone locked Unlock →

Andrés Bratt-Leal

Co-Founder

Work email & phone locked Unlock →

Damien McDevitt

President and Chief Executive Officer

Work email & phone locked Unlock →

Jeanne Loring

Founder

Work email & phone locked Unlock →

Kameel Farag

CFO

Work email & phone locked Unlock →

Kim Raineri

Chief Technology Officer

Work email & phone locked Unlock →

Lisa Johnson-Pratt

Senior Vice President, Therapeutic Program Lead

Work email & phone locked Unlock →

Xiaokui Zhang

Chief Scientific Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts